Helen C. Kales, M.D., professor of psychiatry, is one of 20 international dementia experts named to The Lancet Commission on Dementia Care. The Lancet has partnered with leading academic and charitable institutions (University College London, Alzheimer’s Society, ESRC and Alzheimer’s Research U.K.) to establish a Commission on Dementia Care. The Commission is reviewing the current
Aside from memory loss and cognitive impairments, often the most difficult aspect of caring for people with dementia is treating their disruptive changes in behavior. With no reliable medications to treat them and limited information for caregivers regarding alternative therapies, these behavior changes are frequently the source of increased upset, stress and burden to families
Journal Watch Psychiatry has named a University of Michigan Health System study as one of the top 10 stories of 2012. The study – whose lead author is Helen C. Kales, M.D., associate professor of psychiatry at the U-M Medical School and researcher at the VA Ann Arbor Healthcare System – evaluated how antipsychotics affect
Antipsychotic medications are routinely prescribed to older patients with Parkinson’s disease, a pattern that has remained steady despite a warning from the Food and Drug Administration about the risk of death in elderly adults with dementia. This finding comes from a study published in the Archives of Neurology that was featured in the Wall Street
University of Michigan Department of Psychiatry and Depression Center Newsroom